Is it necessary to have routine blood tests in patients treated with isotretinoin?

Objectives: Several side effects can be observed from isotretinoin use, which has been used in acne therapy for years. In this study, the side effects of isotretinoin on skin and mucosa, blood test changes and their relation with total dose were investigated in patients who used equal doses of isotretinoin. Materials and methods: A total of 91 outpatients with acne vulgaris (57 females and 34 males; age range 17–28 years, mean 21±2.19 years) were enrolled in this study. Skin and mucosal findings and pre‐ and post‐treatment blood tests and their correlation with the total dose were investigated. Student's t‐test and the Mann–Whitney U‐test were used in the statistical analyses. Results: In all, 89 out of 91 patients completed the study. Cholesterol (p = 0.00), triglyceride (p = 0.00) and low density lipoprotein (LDL) (p = 0.001) levels were found to be significantly elevated. But these values were not over the double of the upper limits. No correlations were found among the total dose and the skin and mucosal changes as well as the blood test results. Conclusion: It is concluded that examination of cholesterol, triglyceride and LDL‐cholesterol should be performed monthly if the initial blood tests are close to the upper limits; otherwise, examinations at 2‐ or 3‐month intervals are sufficient, which would save unnecessary costs.

[1]  W. Cunliffe,et al.  Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic‐resistant propionibacteria in patients with acne , 2005, The British journal of dermatology.

[2]  E. Tanghetti Combination therapy is the standard of care. , 2005, Cutis.

[3]  M. Placa Acute depression from isotretinoin. Another case. , 2005 .

[4]  N. Al‐Mutairi,et al.  Isotretinoin in acne vulgaris: a prospective analysis of 160 cases from Kuwait. , 2005, Journal of drugs in dermatology : JDD.

[5]  M. La Placa Acute depression from isotretinoin. Another case , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  G. Haroske,et al.  Psoriasis and Brooke–Spiegler syndrome with multiple malignancies , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  S. Feldman,et al.  Trends in prescription of acne medication in the US: Shift from antibiotic to non‐antibiotic treatment , 2005, The Journal of dermatological treatment.

[8]  K. Bahamdan,et al.  Isotretinoin therapy: any need for laboratory assessment? , 2005, West African journal of medicine.

[9]  Arthur Rook,et al.  Rook's Textbook of Dermatology , 2004 .

[10]  J. Barth,et al.  Retrospective survey of serum lipids in patients receiving more than three courses of isotretinoin , 2003, The Journal of dermatological treatment.

[11]  Karen E. Moeller,et al.  Prolonged Thrombocytopenia Associated with Isotretinoin , 2003, The Annals of pharmacotherapy.

[12]  C. Zouboulis,et al.  Update and Future of Systemic Acne Treatment , 2003, Dermatology.

[13]  R. Altman,et al.  A Proposed Set of New Guidelines for Routine Blood Tests during Isotretinoin Therapy for Acne vulgaris , 2002, Dermatology.

[14]  J. Alcalay,et al.  Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests? , 2001, The Journal of dermatological treatment.

[15]  F. Serri,et al.  Acute depression from isotretinoin. , 1991, Journal of the American Academy of Dermatology.

[16]  A. Vahlquist,et al.  Changes in laboratory variables induced by isotretinoin treatment of acne. , 1986, Acta dermato-venereologica.